Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients

Abstract

When combined with risk-appropriate genetic counseling, detection of VUS did not lead to excessive CPM in this cohort of triple-negative breast cancer patients. Furthermore, panel testing detected mutations in non-breast cancer-associated genes, which had significant implications on management and outcomes.